Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

[Botulinum toxin in the head and neck region].

Laskawi R.

HNO. 2012 Jun;60(6):474. doi: 10.1007/s00106-011-2478-6. German. No abstract available.

PMID:
22669433
2.

[Botulinum toxin for the treatment of secretory disorders of the head and neck area].

Steffen A.

HNO. 2012 Jun;60(6):484-9. doi: 10.1007/s00106-012-2498-x. German.

PMID:
22669436
3.

Botox for chronic migraine.

[No authors listed]

Drug Ther Bull. 2011 Feb;49(2):22-4; quiz iii-iv. doi: 10.1136/dtb.2010.10.0008. Review.

PMID:
21304165
4.

Introduction. Botox.

Klein AW.

Dis Mon. 2002 May;48(5):296-8. No abstract available.

PMID:
12195261
5.

Sustained benefit of painful legs moving toes syndrome with botulinum toxin type A.

Rodriguez RL, Fernandez HH.

J Clin Neurosci. 2013 Jul;20(7):1031-2. doi: 10.1016/j.jocn.2012.06.016.

PMID:
23582954
6.

Head and neck muscle spasm after radiotherapy: management with botulinum toxin A injection.

Van Daele DJ, Finnegan EM, Rodnitzky RL, Zhen W, McCulloch TM, Hoffman HT.

Arch Otolaryngol Head Neck Surg. 2002 Aug;128(8):956-9.

PMID:
12162778
7.

Clinical utility of different botulinum neurotoxin preparations.

Abrams SB, Hallett M.

Toxicon. 2013 Jun 1;67:81-6. doi: 10.1016/j.toxicon.2012.11.024. Review.

PMID:
23375537
8.

The use of botulinum toxin in head and face medicine: an interdisciplinary field.

Laskawi R.

Head Face Med. 2008 Mar 10;4:5. doi: 10.1186/1746-160X-4-5. Review.

9.
10.

Botulinum toxin for muscle spasm after tetanus.

Gaber TA, Mannemela S.

J R Soc Med. 2005 Feb;98(2):63. No abstract available.

11.

Botulinum toxin A and migraine surgery.

Guyuron B, Tucker T, Kriegler J.

Plast Reconstr Surg. 2003 Oct;112(5 Suppl):171S-173S; discussion 174S-176S. No abstract available.

PMID:
14504501
12.

Use of botulinum toxin A for treatment of myofascial pain and dysfunction.

Fallah HM, Currimbhoy S.

J Oral Maxillofac Surg. 2012 May;70(5):1243-5. doi: 10.1016/j.joms.2012.01.015. No abstract available.

PMID:
22538024
13.

OnabotulinumtoxinA for the treatment of chronic migraine not quite there. . .

Torgovnick J.

Cephalalgia. 2011 Feb;31(3):377; author reply 378-9. doi: 10.1177/0333102410388529. No abstract available.

PMID:
21098110
14.

There is value in anecdotal reports of relief from migraine with botulinum toxin.

Winett B.

J Manag Care Pharm. 2009 Jan-Feb;15(1):78; author reply 78-9. No abstract available.

15.

Application of botulinum toxin to clinical therapy: advances and cautions.

Levy NS, Lowenthal DT.

Am J Ther. 2012 Jul;19(4):281-6. doi: 10.1097/MJT.0b013e3181e9b655.

PMID:
22481607
16.

OnabotulinumtoxinA for chronic migraine.

Blumenfeld A, Evans RW.

Headache. 2012 Jan;52(1):142-8. doi: 10.1111/j.1526-4610.2011.02081.x. No abstract available.

PMID:
22268776
17.

Botulinum toxin for chronic migraine.

[No authors listed]

Med Lett Drugs Ther. 2011 Jan 24;53(1356):7-8. No abstract available.

PMID:
21252842
18.

[Botulinum toxin type A for preventive treatment of chronic migraines].

Göbel H, Heinze A.

HNO. 2012 Jun;60(6):490-5. doi: 10.1007/s00106-012-2496-z. German.

PMID:
22669437
19.

Botulinum toxin type A and acute drug costs in migraine with triptan overuse.

Christie SN, Giammarco R, Gawel M, Mackie G, Gladstone J, Becker WJ.

Can J Neurol Sci. 2010 Sep;37(5):588-94.

PMID:
21059503
20.

Botulinum toxin. From poison to medical wonder.

[No authors listed]

Mayo Clin Health Lett. 2006 Dec;24(12):4-5. No abstract available.

PMID:
17310508

Supplemental Content

Support Center